항콕시듐제 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 약제클래스별, 작용기서별, 동물 유형별, 유통경로별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Anticoccidial Drugs Market, valued at USD 1.41 Billion in 2024, is projected to experience a CAGR of 3.96% to reach USD 1.78 Billion by 2030. Anticoccidial drugs are pharmaceutical agents developed to prevent and treat coccidiosis, a parasitic disease primarily impacting the intestinal tracts of livestock, particularly poultry, caused by protozoa of the genus *Eimeria*. The market's growth is fundamentally supported by the escalating global demand for animal protein, leading to intensive farming practices that increase coccidiosis incidence.

Key Market Drivers

The global anticoccidial drugs market experiences significant expansion driven by the escalating prevalence of coccidiosis in livestock and poultry, coupled with a growing global demand for animal protein. The widespread nature of coccidiosis, caused by *Eimeria* protozoa, consistently necessitates effective pharmaceutical interventions to maintain animal health and productivity.

Key Market Challenges

The continuous development of drug-resistant coccidia strains presents a significant impediment to the growth of the Global Anticoccidial Drugs Market. This pervasive issue directly undermines the effectiveness of existing pharmaceutical treatments, necessitating constant innovation and substantial investment in research and development for novel compounds and treatment strategies. As existing drugs become less potent against evolved parasite strains, their market value and utility diminish, compelling manufacturers to shoulder considerable costs for developing new solutions. This prolonged and costly development cycle for effective new drugs, coupled with the shortened effective lifespan of current products due to resistance, directly stifles overall market expansion.

Key Market Trends

The shift towards natural and probiotic-based coccidiosis management represents a significant trend, driven by increasing consumer demand for residue-free animal products and the industry's need to address drug resistance challenges. Producers are increasingly incorporating feed additives, such as probiotics and prebiotics, to foster robust gut health and enhance the animals' natural immunity. This approach reduces reliance on conventional anticoccidial drugs.

Key Market Players

• Vetoquinol SA
• Zoetis Philippines Inc.
• Phibro Animal Health Corporation
• Huvepharma, Inc.
• Elanco US Inc.
• Biochem Pharmaceutical Industries Ltd
• Ceva Sante Animale SA
• Impextraco NV
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.

Report Scope:

In this report, the Global Anticoccidial Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anticoccidial Drugs Market, By Drug Class:

• Ionophore
• Antibiotic
• Sulphonamides
• Chemical Derivative
• Other Drug Classes

Anticoccidial Drugs Market, By Drug Action:

• Coccidiostatic
• Coccidiocidal

Anticoccidial Drugs Market, By Animal Type:

• Production Animals
• Companion Animals

Anticoccidial Drugs Market, By Distribution Channel:

• Veterinary Hospitals
• Retail Pharmacy
• Other Distribution Channels

Anticoccidial Drugs Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Anticoccidial Drugs Market.

Available Customizations:

Global Anticoccidial Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anticoccidial Drugs Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes)
  • 5.2.2. By Drug Action (Coccidiostatic, Coccidiocidal)
  • 5.2.3. By Animal Type (Production Animals, Companion Animals)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Anticoccidial Drugs Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Drug Class
  • 6.2.2. By Drug Action
  • 6.2.3. By Animal Type
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anticoccidial Drugs Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Drug Class
      • 6.3.1.2.2. By Drug Action
      • 6.3.1.2.3. By Animal Type
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Anticoccidial Drugs Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Drug Class
      • 6.3.2.2.2. By Drug Action
      • 6.3.2.2.3. By Animal Type
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Anticoccidial Drugs Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Drug Class
      • 6.3.3.2.2. By Drug Action
      • 6.3.3.2.3. By Animal Type
      • 6.3.3.2.4. By Distribution Channel

7. Europe Anticoccidial Drugs Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Class
  • 7.2.2. By Drug Action
  • 7.2.3. By Animal Type
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anticoccidial Drugs Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Drug Class
      • 7.3.1.2.2. By Drug Action
      • 7.3.1.2.3. By Animal Type
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Anticoccidial Drugs Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Drug Class
      • 7.3.2.2.2. By Drug Action
      • 7.3.2.2.3. By Animal Type
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Anticoccidial Drugs Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Drug Class
      • 7.3.3.2.2. By Drug Action
      • 7.3.3.2.3. By Animal Type
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Anticoccidial Drugs Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Drug Class
      • 7.3.4.2.2. By Drug Action
      • 7.3.4.2.3. By Animal Type
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Anticoccidial Drugs Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Drug Class
      • 7.3.5.2.2. By Drug Action
      • 7.3.5.2.3. By Animal Type
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Anticoccidial Drugs Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Drug Class
  • 8.2.2. By Drug Action
  • 8.2.3. By Animal Type
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anticoccidial Drugs Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Drug Class
      • 8.3.1.2.2. By Drug Action
      • 8.3.1.2.3. By Animal Type
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Anticoccidial Drugs Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Drug Class
      • 8.3.2.2.2. By Drug Action
      • 8.3.2.2.3. By Animal Type
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Anticoccidial Drugs Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Drug Class
      • 8.3.3.2.2. By Drug Action
      • 8.3.3.2.3. By Animal Type
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Anticoccidial Drugs Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Drug Class
      • 8.3.4.2.2. By Drug Action
      • 8.3.4.2.3. By Animal Type
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Anticoccidial Drugs Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Drug Class
      • 8.3.5.2.2. By Drug Action
      • 8.3.5.2.3. By Animal Type
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Anticoccidial Drugs Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Drug Class
  • 9.2.2. By Drug Action
  • 9.2.3. By Animal Type
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anticoccidial Drugs Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Drug Class
      • 9.3.1.2.2. By Drug Action
      • 9.3.1.2.3. By Animal Type
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Anticoccidial Drugs Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Drug Class
      • 9.3.2.2.2. By Drug Action
      • 9.3.2.2.3. By Animal Type
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Anticoccidial Drugs Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Drug Class
      • 9.3.3.2.2. By Drug Action
      • 9.3.3.2.3. By Animal Type
      • 9.3.3.2.4. By Distribution Channel

10. South America Anticoccidial Drugs Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Drug Class
  • 10.2.2. By Drug Action
  • 10.2.3. By Animal Type
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anticoccidial Drugs Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Drug Class
      • 10.3.1.2.2. By Drug Action
      • 10.3.1.2.3. By Animal Type
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Anticoccidial Drugs Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Drug Class
      • 10.3.2.2.2. By Drug Action
      • 10.3.2.2.3. By Animal Type
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Anticoccidial Drugs Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Drug Class
      • 10.3.3.2.2. By Drug Action
      • 10.3.3.2.3. By Animal Type
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anticoccidial Drugs Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Vetoquinol SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zoetis Philippines Inc.
• 15.3. Phibro Animal Health Corporation
• 15.4. Huvepharma, Inc.
• 15.5. Elanco US Inc.
• 15.6. Biochem Pharmaceutical Industries Ltd
• 15.7. Ceva Sante Animale SA
• 15.8. Impextraco NV
• 15.9. Boehringer Ingelheim International GmbH
• 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer